Antibody blocking of MHC II on human activated regulatory T cells abrogates their suppressive potential

Allergy. 2007 Jul;62(7):773-80. doi: 10.1111/j.1398-9995.2007.01339.x.

Abstract

Natural regulatory CD4(+)CD25(+)Foxp3(+) T cells control peripheral immune responses. Freshly isolated regulatory T-cell populations are regarded as being unable to suppress the proliferation of strongly stimulated effector T cells. We now provide evidence that it is not the strength of the proliferative signal to effector T cells but activation and accessibility of regulatory T cells that determine whether suppression may occur. Human regulatory T cells were initially cocultured with allogeneic monocyte-derived dendritic cells for a short time and were then rendered accessible for effector T cells by removal of the dendritic cells. That way activated regulatory T cells effectively suppressed the proliferation of autologous effector T cells which was strongly driven by cell-sized Dynabeads coated with CD3/CD28 antibodies. Although regulatory T cells are known to display MHC II molecules and to upregulate their expression along with activation, a role of MHC II molecules in forming the contact to effector T cells was not yet envisaged. However, blocking of MHC II on activated regulatory T cells abrogated their suppressive potential. It should not be excluded that self-MHC molecules on physically accessible activated regulatory T cells arrange the contact to effector T cells.

MeSH terms

  • Antibodies / pharmacology*
  • Cell Communication / immunology
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques
  • Dendritic Cells
  • Histocompatibility Antigens Class II / immunology*
  • Humans
  • Immune Tolerance / drug effects*
  • Lymphocyte Activation / immunology
  • T-Lymphocytes, Regulatory / drug effects*
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Antibodies
  • Histocompatibility Antigens Class II